CDT EQUITY INC. Long-term Debt, Gross
CDT EQUITY INC. (CDT) had Long-term Debt, Gross of $200.00 thousand as of 2024-10-09, per its 10-K filed 2025-03-28.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2025-03-28
- 2024-10-09: Long-term Debt, Gross $200.00K.
| Period end | Long-term Debt, Gross |
|---|---|
| 2024-10-09 | $200.00K 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |